DUDLEY ROBERT MICHAEL (Chief Executive Officer) purchased 2.1% of their position (19K shares) of TRANSCODE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $52.4K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/13/2023ACC: 0001104659-23-070804
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2021
+19K
Net shares
Net buyer
$52.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
19K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+19K
Price / share
$2.76
Trade value
$52.44K
% of position
2.1%
6/9/2023
893.11K→912.11K
Total
Net shares
+19K
Net value
$52.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2023 | P · Purchase | +19K | $2.76 | $52.44K | 2.1% | 893.11K | 912.11K |
| Total | +19K | $52.44K | ||||||
Derivative Transactions0
No derivative transactions reported